TrialReader


e-Cigarette - DNA Adducts

NCT03284632 — Completed, 217 participants, University of Minnesota

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

e-Cigarettes: Formaldehyde DNA Adducts, Oxidative Damage, and Potential Toxicity and Carcinogenesis

RegistryNCT03284632
StatusCompleted
Study typeObservational
Enrollment217 (Actual)
SponsorUniversity of Minnesota (Other); collaborators: National Institutes of Health (NIH)
ConditionsSmoking, Cigarette Smoking, Electronic Cigarettes
Datesstart 2017-07-11, primary completion 2021-06-01, completion 2021-06-01, first posted 2017-09-15, last updated 2022-11-09
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Smoking All trials for Cigarette Smoking

-Summary

This study will examine the level of toxicity of e-cigarette use compared to smokers and nonsmokers including inflammation markers, toxicant and carcinogen exposure. Additionally, the study will look at the effect of varying voltage levels for e-cigarette users.

Expand all sections  ·  Collapse all

+Detailed description

In this observational study, e-cigarette users, smokers, and non-users of e-cigarette or tobacco products (up to 134 per group) will be recruited from the Minneapolis-St. Paul area. This research will be conducted at the Tobacco Research Programs at the University of Minnesota. Subjects are screened for eligibility over the phone. If eligible after the phone screen, participants will be invited to attend orientation screening visit in the clinic where consent will be obtained and subjects will complete forms about their tobacco and e-cigarette use and medical history. Subjects who eligible will be asked to return for six visits over the course of six months.

At these appointments, subjects will provide biological specimen samples (buccal cells, urine and blood). Saliva will be collected before and after a smoking or vaping session. Non-users will only have 1 saliva collection.

Subjects will be asked for information pertaining to and e-cigarette and tobacco use and overall health.

+Arms and interventions

ArmTypeInterventionsDescription
Smokers
E-cigarette users
Non-smokers

+Outcome measures

Primary outcomes

  • DNA Adducts [6 months]: Formation of Formaldehyde DNA Adducts in oral cells before and after smoking or vaping

Secondary outcomes

  • Urinary 8-iso-PGF-2α [6 months]: Stability of Urinary 8-iso-PGF-2α (biomarkers of oxidative damage) over a 6-month sample period
  • Urinary PGEM [6 months]: Stability of Urinary PGEM (biomarker of inflammation) over a 6-month sample period
  • C-reactive protein [6 months]: Stability of C-reactive protein in serum (biomarker of inflammation) over a 6-month sample period
  • TNE [6 months]: Total Nicotine Equivalents (nicotine exposure) over a 6-month sample period

+Eligibility

Sex: All, ages: 18 Years to any, accepts healthy volunteers

Inclusion Criteria:

* Good physical health with no unstable medical conditions; Able to provide written informed consent; Stable and good mental health;

Meet criteria for 1 of three groups:

1. Regular smokers confirmed by CO;
2. E-cigarette users (exclusive e-cigarette use for 3 months); Non-Tobacco Users
3. Non-smokers

Exclusion Criteria:

* Unstable medical condition Not willing to attend visits

+Locations (1)

FacilityCityCountryStatus
University of MinnesotaMinneapolis, MinnesotaUnited States

+Investigators

My Notes